8-KRegulation FDOther EventsExhibits & Filings

UNITEDHEALTH GROUP INC 8-K Report, Regulation FD Disclosure (Dec 19, 2006)

Filed December 19, 2006For Securities:UNH

Summary

UnitedHealth Group Inc. (UNH) filed an 8-K on December 19, 2006, primarily to disclose information presented at its annual investor conference. The most significant aspect of this filing is the extensive discussion around the ongoing review of the company's historical stock option practices. This review, initiated in early 2006 and conducted by independent directors and advisors, has led to the conclusion that historical financial statements from 1994 to 2005, and interim periods through Q3 2006, should no longer be relied upon due to incorrect measurement dates for stock option grants. The company is in the process of restating these financials and is consulting with the SEC's Office of the Chief Accountant regarding accounting adjustments, particularly for non-cash stock-based compensation expenses under APB 25 and FAS 123R.

Key Highlights

  • 1UnitedHealth Group (UNH) is facing significant accounting and financial reporting challenges due to historical stock option practices, necessitating a restatement of financial statements from 1994-2005.
  • 2The company has identified incorrect measurement dates for stock option grants, meaning prior financial statements and earnings releases are unreliable.
  • 3UNH has substantially completed its analysis of necessary accounting adjustments for stock-based compensation and is consulting with the SEC.
  • 4The ongoing restatement has led to delayed filings of Q2 and Q3 2006 Form 10-Qs, and impacts the company's ability to issue new securities and potentially its credit rating.
  • 5Various regulatory inquiries (SEC, IRS, SDNY US Attorney, MN AG) and litigation (class actions, derivative suits) are ongoing related to stock option practices.
  • 6The company has updated its 2006 and 2007 outlooks, which reflect estimates of additional stock-based compensation charges and are subject to change pending finalization of the restatement.
  • 7UNH has secured new credit facilities totaling $8.5 billion to ensure liquidity during this period of financial reporting uncertainty.

Frequently Asked Questions

This 8-K filing is primarily to disclose information presented at UnitedHealth Group's annual investor conference, which includes updates on their 2006 and 2007 outlook and significant developments regarding their historical stock option practices.

The review has concluded that historical financial statements from 1994 through 2005, and interim periods in 2006, should no longer be relied upon. The company is undergoing a restatement process to correct accounting for stock-based compensation, which has led to delayed SEC filings and potential impacts on capital raising and credit ratings.

The company provided an updated outlook for 2006 and 2007. These outlooks incorporate estimates of additional non-cash charges related to stock-based compensation arising from the stock option review. However, these estimates are not final and are subject to change based on the finalization of the financial restatement and other potential impacts like tax matters and litigation.

UnitedHealth Group is subject to informal inquiries from the SEC, document requests from the IRS and the U.S. Attorney for the Southern District of New York, and a Civil Investigative Demand from the Minnesota Attorney General, all related to historical stock option practices. Additionally, the company faces consolidated federal securities class action and state/federal shareholder derivative lawsuits concerning these same practices.